Top Story

Ninlaro maintenance therapy extends PFS in posttransplant myeloma

July 11, 2018
In the Journals Plus

American Cancer Society creates blueprint to reduce cancer mortality by 2035

July 10, 2018
Researchers from the American Cancer Society identified trends in disparities and outcomes for cancer over the last few decades in an effort to highlight the need for…

Stand Up To Cancer dream team strives to revolutionize myeloma treatment

June 29, 2018
Stand Up To Cancer awarded a $10 million grant to a research “dream team” that will strive to revolutionize the treatment of multiple myeloma through early…

Survivin may be target for immunotherapies in several malignancies

June 27, 2018
Survivin, an inhibitor of apoptosis protein, may be an attractive target for a variety of immunotherapeutic approaches for cancer, according to study results. Survivin…
More Headlines »

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing over the past 3 Months

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who…
More »

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting


Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

The integration of immune checkpoint inhibitors into treatment algorithms for patients with bladder cancer who have…
More »